DATROWAY® (datopotamab deruxtecan) has been approved in the European Union (EU) for the treatment of adult patients with ...

The European Commission approves AstraZeneca's Enhertu for a new breast cancer indication while also expanding Imfinzi label ...

Experts discuss how, there is a role for SRS in treating brain metastases such as if a patient were to have a large singular brain metastasis that is causing symptoms such as seizures of neurological ...

Biomarkers can shape a breast cancer treatment plan, Andy Guinigundo explained in an interview with CURE.

An experimental breast cancer vaccine at Moffitt Cancer Center in Tampa created a unique bond between a patient and a cell ...

The FDA cleared the investigational new drug application for ALX2004, with phase 1 trials expected to begin in mid-2025 for ...

Raymond James Financial Inc. purchased a new stake in Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) during the fourth ...

Tahira Kashyap's breast cancer relapsed, she shared on Instagram. She also highlighted the importance of regular screening.

Duality Biologics has begun (PDF) offering stock, wading into a market reeling from Presid | Duality Biologics has begun ...

Piper Sandler lowered the firm’s price target on Arvinas (ARVN) to $24 from $67 on narrowed vepdegestrant ESR1-mutant mBC approval, while ...

Blueprint Medicines Corporation focuses on Ayvakit, BLU-808, and Elenestinib with strong potential in mast cell disorders.

Although the risk of striking breast cancer to teenagers is slightly low, yet it can occur in any age. However it is most ...